Page last updated: 2024-08-21

homocystine and Coronary Disease

homocystine has been researched along with Coronary Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's6 (60.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballman, KV; Berger, PB; Brilakis, ES; Rozen, R1
Genest, J; Mikael, LG; Rozen, R1
Aull, S; Deecke, L; Lalouschek, W; Schnider, P; Uhl, F; Zeiler, K1
Herzlich, BC1
Wang, XL; Wilcken, B; Wilcken, DE1
Anderson, PH; Block, PC; Duell, PB; Gluckman, RA; Hess, DL; Kruger, WD; Malinow, MR; Phillipson, BE; Upson, BM1
Kitamura, K; Kurihara, H; Morita, H; Sugiyama, T; Sumiyoshi, T; Suzuki, S; Yazaki, Y1
Berg, K; Kierulf, P; Malinow, MR; Upson, B1
Cook, HY; Kang, SS; Messer, JV; Norusis, M; Wong, PW1
Feit, F; Fox, AC; Gaull, GE; Glassman, E; Grieco, AJ; Heininger, JA; Murphy-Chutorian, DR; Ng, SK; Wexman, K; Wexman, MP1

Reviews

1 review(s) available for homocystine and Coronary Disease

ArticleYear
[Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Fortschritte der Neurologie-Psychiatrie, 1996, Volume: 64, Issue:7

    Topics: Amino Acid Metabolism, Inborn Errors; Arterial Occlusive Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Homocystine; Humans; Risk Factors

1996

Trials

1 trial(s) available for homocystine and Coronary Disease

ArticleYear
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
    The New England journal of medicine, 1998, Apr-09, Volume: 338, Issue:15

    Topics: Aged; Aged, 80 and over; Coronary Disease; Cross-Over Studies; Double-Blind Method; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Homocystine; Humans; Male; Middle Aged; Nutrition Policy; Vitamins

1998

Other Studies

8 other study(ies) available for homocystine and Coronary Disease

ArticleYear
Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid.
    Atherosclerosis, 2003, Volume: 168, Issue:2

    Topics: Adenine; Aged; Coronary Angiography; Coronary Disease; Cytosine; Female; Ferredoxin-NADP Reductase; Flour; Folic Acid; Food, Fortified; Genotype; Homocystine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Repressor Proteins; Thymine

2003
Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
    Circulation research, 2006, Mar-03, Volume: 98, Issue:4

    Topics: Animals; Apolipoprotein A-I; Cholesterol 7-alpha-Hydroxylase; Cholesterol, HDL; Coronary Disease; Cystathionine beta-Synthase; Homocystine; Hyperhomocysteinemia; Liver; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; PPAR alpha; Promoter Regions, Genetic; RNA, Messenger

2006
Plasma homocyst(e)ine, folate, vitamin B6 and coronary artery disease risk.
    Journal of the American College of Nutrition, 1996, Volume: 15, Issue:2

    Topics: Adult; Coronary Disease; Folic Acid; Homocystine; Humans; Pyridoxine; Risk Factors

1996
Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
    Circulation, 1997, Oct-21, Volume: 96, Issue:8

    Topics: Adult; Coronary Disease; Homocysteine; Homocystine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies

1997
[Genetic polymorphisms of methylenetetrahydrofolate reductase and methionine synthase: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population].
    Journal of cardiology, 1999, Volume: 33, Issue:2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Alleles; Asian People; Cerebral Infarction; Coronary Disease; Homocystine; Humans; Japan; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic

1999
Population variation and genetics of plasma homocyst(e)ine level.
    Clinical genetics, 1992, Volume: 41, Issue:6

    Topics: Adult; Analysis of Variance; Apolipoproteins; Coronary Disease; Female; Fibrinogen; Homocysteine; Homocystine; Humans; Lipids; Male; Middle Aged; Norway; Twins; Twins, Dizygotic; Twins, Monozygotic

1992
Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:5

    Topics: Adult; Age Factors; Aged; Blood Proteins; Coronary Disease; Female; Homocysteine; Homocystine; Humans; Male; Menopause; Middle Aged; Protein Binding; Risk; Sex Factors

1986
Methionine intolerance: a possible risk factor for coronary artery disease.
    Journal of the American College of Cardiology, 1985, Volume: 6, Issue:4

    Topics: Adult; Aged; Coronary Disease; Homocystine; Humans; Male; Metabolic Diseases; Methionine; Middle Aged; Risk

1985